Trexquant Investment LP Sells 65,236 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Trexquant Investment LP cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 28.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 164,353 shares of the medical device company’s stock after selling 65,236 shares during the quarter. Trexquant Investment LP owned 0.08% of Cooper Companies worth $15,109,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies during the fourth quarter valued at $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the fourth quarter worth approximately $34,000. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies in the fourth quarter worth approximately $38,000. West Financial Advisors LLC purchased a new position in shares of Cooper Companies during the fourth quarter valued at approximately $49,000. Finally, Atala Financial Inc purchased a new stake in Cooper Companies in the fourth quarter worth approximately $51,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 3.7 %

COO opened at $81.27 on Wednesday. The stock has a market cap of $16.25 billion, a price-to-earnings ratio of 41.68, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm’s fifty day moving average is $88.87 and its 200 day moving average is $96.83. The Cooper Companies, Inc. has a fifty-two week low of $77.05 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on COO shares. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Piper Sandler reissued an “overweight” rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Finally, Citigroup cut their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.